Clinical Trials on HCV-1 in Norway

Total 139 results

Bionor Immuno AS

Completed

Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART

HIV-1 Infection

Norway
University of Tromso
Norwegian Council for Mental Health; The Dam Foundation; Norwegian Directorate...

Active, not recruiting

Opp - a Universal Mental Health Promoting Mobile Application for Adolescents (Opp)

Mental Health Wellness 1

Norway
St. Olavs Hospital

Recruiting

Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1

Type 1 Diabetes

Norway
Oslo University Hospital
Karolinska University Hospital; Tine

Completed

The Effect of Probiotics in HIV-1 Infection (ProGut)

HIV-1 Infection

Norway, Sweden
Oslo University Hospital

Completed

Cardiovascular Risk Factors After Single Pancreas Transplantation (Diamant)

Diabetes Type 1 | Endothelial Dysfunction

Norway
Oslo University Hospital

Unknown

Evaluation of Implementation of Pre-exposure Prophylaxis (PrEP) in Norway

Sexually Transmitted Diseases | Hiv | Mental Health Wellness 1

Norway
Norwegian Institute of Public Health
The Dam Foundation

Recruiting

Effects of the 5 Ways to Wellbeing Course Effects of the 5 Ways to Wellbeing Course (FiveWays)

Quality of Life | Wellbeing | Mental Health Wellness 1

Norway
University of Aarhus
Odense University Hospital; Oslo University Hospital; Rigshospitalet, Denmark; Hvidovre... and other collaborators

Completed

Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV (TITAN)

HIV-1-infection

Norway, Denmark, United States, Australia
Haukeland University Hospital

Terminated

Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes

Type 1 Diabetes | Addison Disease

Norway
Norwegian Institute of Public Health

Completed

Mind Power - A CBT Based Program for Adolescents

Mental Health Wellness 1 | Mental Stress | Mental Depression

Norway
Norwegian School of Sport Sciences
University of Oslo; Oslo University Hospital; University of Copenhagen; University... and other collaborators

Completed

Myotonic Dystrophy Type 1 and Resistance Exercise (STYRK DM1)

Myotonic Dystrophy 1

Norway
Oslo University Hospital

Completed

The Diabetes Virus Detection and Intervention Trial (DiViDInt)

Type1 Diabetes Mellitus | Enterovirus

Norway
University of Oslo
Oslo University Hospital; Vikersund Rehabilitation Center

Completed

Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1 (Technorehab)

Myotonic Dystrophy Type 1 (DM1)

Norway
University Hospital of North Norway
University of Tromso; Norwegian Labour and Welfare Administration; Helse Nord

Active, not recruiting

Health in Work - a Measure for Increased Coping and Work Inclusion (HiAforsk)

Musculoskeletal Pain | Mental Health Wellness 1 | Work-Related Condition

Norway
Sangamo Therapeutics

Terminated

Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T

HIV-1-infection

United States
Oslo University Hospital
University of Oslo; Haukeland University Hospital

Recruiting

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1 (SOUL-DM1)

Myotonic Dystrophy 1

Norway
University Hospital of North Norway
University of Tromso; The Research Council of Norway

Completed

Model Driven Diabetes Care (MDDC)

Diabetes Mellitus, Type 1

Norway
Grill, Valdemar, M.D.

Completed

Efficacy of Diazoxide in Type 1 Diabetes

Diabetes Mellitus, Type 1

Norway
Helse Stavanger HF

Completed

Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes

Diabetes Mellitus, Type 1

Norway
Haukeland University Hospital

Unknown

Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes (SUtoChildT1D)

Insulin-dependent Diabetes Mellitus | Maturity-Onset Diabetes of the Young, Type 3 | Maturity Onset Diabetes of the Young, Type 1 | Childhood Diabetes Mellitus

Norway
Norwegian University of Science and Technology

Completed

Treatment of Latent Autoimmune Diabetes of the Adult (LADA)

Diabetes

Norway
University Hospital, Aker
The Research Council of Norway

Completed

Effects of Vitamin B1 in Type 1 Diabetic Patients

Diabetes Mellitus, Type 1

Norway
Norwegian University of Science and Technology
Norwegian Diabetes Association

Completed

Use of Real-time Continuous Glucose Monitoring System in Patients With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Norway
Haukeland University Hospital
University of Bergen

Recruiting

The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments (FundECT)

Healthy | Major Depressive Disorder | Major Depressive Disorder 1

Norway
Norwegian University of Science and Technology
St. Olavs Hospital; Sykehuset Ostfold

Terminated

The GlucoPred Investigation II (GPI-II)

Diabetes Mellitus, Type 1

Norway
Haukeland University Hospital
University of Bergen; Western Norway University of Applied Sciences

Withdrawn

The Diabetes Patient-Reported Outcome Measures Trial (DiaPROM)

Diabetes Mellitus, Type 1

Norway
Oslo University Hospital
The Dam Foundation; Norwegian Diabetes Association

Terminated

Effectiveness of the Diabetes Body Project Among Females With Type 1 Diabetes (DBP)

Feeding and Eating Disorders | Diabetes Mellitus, Type 1 | Body Image

Norway
ViiV Healthcare
Pfizer

Terminated

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 (MODERN)

HIV-1

United States, Netherlands, Spain, Puerto Rico, Canada, Australia, Germany, Sweden, Poland, Portugal, Switzerland, France, Denmark, Italy, Belgium, United Kingdom, Hungary, Austria, Finland
Dag Kvale
The Research Council of Norway

Completed

Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients (OUSCOX2)

HIV

Norway
Tibotec Pharmaceuticals, Ireland

Completed

The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs

HIV-1

United States, Belgium, Germany, Taiwan, Spain, Mexico, Turkey, Canada, Netherlands, Denmark, Greece, Sweden, Korea, Republic of, Russian Federation, Puerto Rico, Luxembourg
Oslo University Hospital
Juvenile Diabetes Research Foundation; Stanford University; University of Minnesota and other collaborators

Recruiting

Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes

Type 1 Diabetes | Eating Disorders

United States, Norway, Netherlands
Norwegian University of Science and Technology
Karolinska Institutet; Linkoeping University; St. Olavs Hospital; Diamyd Medical...

Completed

Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes (GADinLADA)

Latent Autoimmune Diabetes in Adults

Norway, Sweden
Oslo University Hospital
Eurocine Vaccines AB; Bionor Immuno AS

Completed

Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant

HIV Infection

Norway
National Institute of Allergy and Infectious Diseases...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Clinical...

Completed

Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation

Diabetes Mellitus, Type I

Sweden, Norway
Norwegian School of Sport Sciences
Ostfold University College; University College of Southeast Norway

Completed

Mental Health in Fitness Instructors

Weight Loss | Amenorrhea | Dietary Habits | Weight Gain | Mental Health Wellness 1 | Body Image Disturbance | Exercise Addiction | Depression, Anxiety | Body Image | Eating Disorders | Thinness | Eating Behavior | Weight Change, Body | Sexual Harassment | Leanness

Norway
Oslo University Hospital
University Hospital, Aker

Completed

Long Term Vascular Changes in Type 1 Diabetes (DM09)

Diabetes Mellitus, Type 1 | Coronary Heart Disease | Complications

Norway
Gilead Sciences

Completed

Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)

HIV-1 Infection

United States, Spain, United Kingdom, Netherlands, Germany, Canada, Sweden, Switzerland, Italy, Belgium, Puerto Rico, France
Gilead Sciences

Completed

Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults

HIV-1 Infection

Spain, United States, United Kingdom, Switzerland, Germany, Canada, France, Belgium, Puerto Rico
Ostfold Hospital Trust

Not yet recruiting

The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) (NORWEL)

Progression | Cesarean Section Complications | Labor Complication | Labor Onset and Length Abnormalities | Experience, Life | Labor (Obstetrics)--Complications | Labor Dystocia | Apgar; 4-7 at 1 Minute

Norway
University of Stavanger
Stavanger Municipality, Norway

Recruiting

Health Determinants in Older Adults Living at Home

Frailty | Healthy Aging | Alcohol Use, Unspecified | Mental Health Issue | Social Functioning | Vision and Hearing Loss | Cognitive Function, Social 1

Norway
University of Cambridge
Juvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaborators

Unknown

An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA) (INNODIA)

Type 1 Diabetes Mellitus

Austria, Italy, Finland, Denmark, Germany, Belgium, United Kingdom, France, Luxembourg, Norway, Poland, Slovenia, Sweden
TikoMed AB

Terminated

Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation

Diabetes Mellitus, Type 1

Sweden, Norway, Netherlands
Oslo University Hospital
University of Oslo

Completed

Improving Prognosis in HIV Infection

Human Immunodeficiency Virus

Norway
NordicInfu Care AB

Completed

NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up

Pulmonary Hypertension Group 1 and 4 According to Nice Classification

Denmark, Norway, Sweden
Makerere University
The Norwegian Programme for Development, Research and Higher Education

Completed

Effect of Multiple Micronutrient Supplementation on Growth, Morbidity, and Mortality of HIV Infected Children in Uganda (MMS)

HIV Infections

Norway, Uganda
Diasome Pharmaceuticals
Integrium

Completed

Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1) (ISLE-1)

Type 1 Diabetes Mellitus

United States
Oslo University Hospital
University of Oslo; Ullevaal University Hospital; University Hospital, Akershus

Withdrawn

Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.

Microcephaly | Hearing Loss | Mental Retardation | Chorioretinitis

Norway
Gilead Sciences

Completed

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

HIV | Human Immunodeficiency Virus | HIV-1

United States, Puerto Rico
Eli Lilly and Company

Completed

A Study of LY3209590 in Participants With Type 1 Diabetes

Type 1 Diabetes Mellitus

United States, Spain, Germany, Puerto Rico, Austria
Biomea Fusion Inc.

Recruiting

Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus (BF-MNN-112)

Type 1 Diabetes Mellitus

United States, Canada

Clinical Trials on HCV-1 in Norway

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations